Recurrent or Refractory
2 clinical trials · Condition
◉ Watch Recurrent or Refractory
| Record | Firm | Date |
|---|---|---|
| Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease (NCT07509034) | National Cancer Institute (NCI) | 2026-08-26 |
| A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (NCT05236621) | Qilu Pharmaceutical Co., Ltd. | 2021-01-04 |
Track Recurrent or Refractory automatically
Every clearance here is in the API, with alerts when new ones post.